The Prostate, Lung, Colon, and Ovarian (PLCO) cancer screening trial: status and promise

被引：28

作者：

Andriole, GL

Reding, D

Hayes, RB

Prorok, PC

Gohagan, JK

机构：

[1] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA

[2] Marshfield Med Res & Educ Fdn, Marshfield, WI USA

[3] NCI, Bethesda, MD 20892 USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2004年 / 22卷 / 04期

关键词：

cancer screening; prevention; biorepository;

D O I：

10.1016/j.urolonc.2004.04.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Prostate, Lung, Cancer, and Ovarian Cancer Screening Trial is a randomized, multicenter, study evaluating whether screening for prostate, lung, colon, and ovarian cancer will reduce cancer-specific mortality. More than 155,000 participants have been identified and will be monitored through 2015. A biorepository of screened individuals and control participants has been created. Together, the data derived from the intervention and control arms and material in the biorepository provide a valuable resource to allow identification and testing of novel biomarkers for human disease. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：358 / 361

页数：4

共 4 条

[1] The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status [J].

Gohagan, JK ;

Prorok, PC ;

Hayes, RB ;

Kramer, BS .

CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :251S-272S

[2] Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].

Hayes, RB ;

Reding, D ;

Kopp, W ;

Subar, AF ;

Bhat, N ;

Rothman, N ;

Caporaso, N ;

Ziegler, RG ;

Johnson, CC ;

Weissfeld, JL ;

Hoover, RN ;

Hartge, P ;

Palace, C ;

Gohagan, JK .

CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :349S-355S

[3]

Lum A, 1998, CANCER EPIDEM BIOMAR, V7, P719

[4] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].

Prorok, PC ;

Andriole, GL ;

Bresalier, RS ;

Buys, SS ;

Chia, D ;

Crawford, ED ;

Fogel, R ;

Gelmann, EP ;

Gilbert, F ;

Hasson, MA ;

Hayes, RB ;

Johnson, CC ;

Mandel, JS ;

Oberman, A ;

O'Brien, B ;

Oken, MM ;

Rafla, S ;

Reding, D ;

Rutt, W ;

Weissfeld, JL ;

Yokochi, L ;

Gohagan, JK .

CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :273S-309S

← 1 →